Clinical trial
Natural History of BAG3 Gene Mutation-Associated Dilated Cardiomyopathy in Chinese Adults: A Multicentre, Prospective, Observational Cohort Study
NCT07646600 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Natural History of BAG3 Gene Mutation-Associated Dilated Cardiomyopathy in Chinese Adults: A Multicentre, Prospective, Observational Cohort Study
- Lead sponsor
- AstraZeneca
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- August 18, 2026
- Completion date
- August 31, 2027
- Enrollment
- 10 (estimated)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.
dilated cardiomyopathy